Clomiphene citrate challenge test and serum anti-Müllerian hormone levels in women with menstrual irregularities and/or infertility

Folia Histochemica et Cytobiologica

Volumn 45, Issue SUPPL. 1, 2007, Pages 119-121

  Milewicz, Tomasz ^a   Krzysiek, Józef ^a   Bła̧kała, Barbara ^a   Krzyczkowska Sendrakowska, Magdalena ^a   Radowicki, Stanisław ^b   Kacalska, Olga ^a   Zabińska, Marta ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Anti M llerian hormone; Challenge test; Clomiphene citrate; Infertility; Menstrual irregularities; Women

Indexed keywords

CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; SOMATOMEDIN BINDING PROTEIN 1; THYROTROPIN;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; PROVOCATION TEST; THYROTROPIN BLOOD LEVEL;

EID: 44949100288     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Te Velde ER, Pearson PL. The variability of female reproductive aging. Hum Reprod Update. 2002;8:141-154.
2. Eldar-Geva T, Ben-Chetrit A, Spitz IM et al. Dynamic assays of inhibit B, anti mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod. 2005;20:3178-3183.
3. Kahraman S, Vicdan K, Isik AZ et al. Clomiphene citrate challenge test in the assessment of ovarian reserve before controlled ovarian hyperstimulation for intracytoplasmic sperm injection. Eur J Obstet Gynecol Reprod Biol. 1997;73:177-182.
4. Csemiczky G, Harlin J, Fried G. Predictive power of clomiphene citrate challenge test for failure of in vitro fertilization treatment. Acta Obstet Gynecol Scand. 2002;81:954-961.
5. van Swieten EC, van der Leeuw-Harmsen L, Badings EA, van der Linden PJ. Obesity and Clomiphene Challenge Test as predictors of outcome of in vitro fertilization and intracytoplasmic sperm injection. Gynecol Obstet Invest. 2005;59:220-224.
6. Behringer RR, Finegold MJ, Cate RL. Mullerian inhibiting substance function during mammalian sexual development. Cell. 1994;79:415-425.
7. Rey R, Sabourin JC, Venara M et al.. Anti-Mullerian hormone is a specific marker of sertoli- and granulose-cell origin in gonadal tumors. Hum Pathol. 2000;31:1202-1208.
8. Rajpert-de Meyts E, Jorgensen N, Graem N et al. Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulose cells. J Clin Endocrinol Metab. 1999;84:3836-3844.
9. Durlinger AL, Gruijters MJ, Kramer P et al. Anti-mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology. 2001;142:4891-4899.
10. Lee MM, Donahoe PK, Hasegawa T et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab. 1996;81:571-576.
11. Seifer DB, Mac Laughlin DT, Christian BP, Feng B, Shleden RM. Early follicular serum mullerian inhibitng substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77:468-471.
12. Rooij IAJ, Broekmans FJM, te Velde ER et al. Serum anti Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065-3071.
13. Fried G, Remaeus K, Harlin J et al. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization. J Assist Reprod Genet. 2003;20:167-176.